VRS
MLYS icon

Virginia Retirement Systems’s Mineralys Therapeutics MLYS Stock Holding History

Virginia Retirement Systems’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$339K Buy
+9,350
New +$375K ﹤0.01% 825

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Virginia Retirement Systems's MLYS Position: Q4 2025 in Review

Virginia Retirement Systems opened a new position in Mineralys Therapeutics (MLYS) in Q4 2025: 9,350 shares worth $339K. The stake represents ﹤0.01% of the portfolio and ranks #825 among its holdings.

223 funds tracked by Wall St. Rank hold MLYS as of Q4 2025.

  • Virginia Retirement Systems held 9,350 shares of Mineralys Therapeutics worth $339K as of Q4 2025.
  • Mineralys Therapeutics was a new Virginia Retirement Systems position in Q4 2025.
  • Mineralys Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #825 holding.
  • 223 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.